Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA

Journal Title: NanoWorld Journal - Year 2015, Vol 1, Issue 2

Abstract

RNA interference and the therapeutic applications using small interfering RNA was discovered more than 10 years ago and currently is used in various applications including in therapeutic field. However the research in this field is still in its infancy. Many challenges like safe delivery of targeted siRNA to nucleus and cytosol of cancerous cells without compromising the activity of siRNA needs to be addressed. We have overcome this hurdle with the help of nanotechnology using PLGA hollow nanoparticles (PLGAHNPs) and suppressing the oncogene of MYC transcription factors by using anti myc-siRNAs in human cancer cell lines. siRNA was encapsulated in PLGAHNPs. These spherical PLGAHNPs of size 70 nm had high efficiency of gene release at pH 4.2 under in vitro conditions. Cell penetrating peptide (CPP)- Tat peptide (TAT) and peptide nucleic acidnucleolus localizing signal (PNA-NLS) was used for siRNA delivery without affecting the therapeutic activity of siRNA. The siRNA duplex was prepared using T7 polymerase and double stranded DNA through in vitro transcription. Incubation of the siRNA encapsulated PLGAHNPs functionalized with TAT and PNA-NLS (TAT-siRNA-PNA-PLGAHNPs-siRNA) with cancer cells resulted in reduced cell proliferation. A downregulation of gene expression by 90% was observed even with low concentration of siRNA. We found complete arrest of cell division which was mediated by downregulation of MYC expression.

Authors and Affiliations

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, D. Sakthi Kumar

Keywords

Related Articles

Strategy for Energy and Environment After Paris

A new version of the World Economic Forum focused on Energy and Environment as proposed by Prime Minister of Japan Shinzō Abe is fundamental after adopting the Paris Agreement, considering that this third Innovation for...

Quasi-QSPR to Predict Proteins Behavior Under Various Concentrations of Drug Using Nanoconductometric Assay

Conductometric monitoring of drug-gene and drug-protein interactions is of fundamental importance in functional proteomics. Here, we model our previously obtained findings and characterizations of an important antiblasti...

Anodizing of Aluminum for Solar Cell Application

The aim of this research is to use the porosity property in anodic alumina to produce well-ordered silicon Nanowires for solar cell applications. The study uses a single step anodizing process as a main process in the ex...

Regenerative Medicine on the Verge of the 4th Industrial Revolution: What We May Envision When the Physical, the Biological and the Digital Converge

Rhythmic oscillatory patterns permeate the entire universe and sustain cellular dynamics at biological level. There is compelling evidence that our cells are sensitive to physical stimulation and can be exposed to physic...

Poly-lactic-co-glycolic acid Nanoformulation of Small Molecule Antagonist GANT61 for Cancer Annihilation by Modulating Hedgehog Pathway

Targeting the self-renewal pathways (SRPs) in cancer has become one of the futuristic treatment strategies in order to prevent cancer relapse and drug resistance. One of the embryonic SRPs, Hedgehog (Hh) pathway is found...

Download PDF file
  • EP ID EP223085
  • DOI 10.17756/nwj.2015-005
  • Views 140
  • Downloads 0

How To Cite

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, D. Sakthi Kumar (2015). Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA. NanoWorld Journal, 1(2), 32-45. https://europub.co.uk/articles/-A-223085